During the past decade, ASL1 Avezzano-Sulmona-L'Aquila conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "ASL1 Avezzano-Sulmona-L'Aquila" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "Centro Servizi ANMCO S.r.l." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "ASL1 Avezzano-Sulmona-L'Aquila" are "Acute Coronary Syndrome" (1 trials), "Acute Coronary Syndromes" (1 trials), "Atrial Fibrillation" (1 trials), "Autoinflammatory Syndrome, Unspecified" (1 trials) and "Basal Cell Carcinoma" (1 trials). Many other conditions were trialed in "ASL1 Avezzano-Sulmona-L'Aquila" in a lesser frequency.

Most popular intervention types in "ASL1 Avezzano-Sulmona-L'Aquila" are "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acute coronary syndrome and PCI and AF" (1 trials), "No intervention is foreseen by the protocol." (1 trials) and "sonidegib" (1 trials). Other intervention names were less common.

The vast majority of trials in "ASL1 Avezzano-Sulmona-L'Aquila" are 4 trials for "All" genders.

Currently, there are NaN active trials in "ASL1 Avezzano-Sulmona-L'Aquila". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in ASL1 Avezzano-Sulmona-L'Aquila, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ASL1 Avezzano-Sulmona-L'Aquila, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".